1 - 10 of about 1489 releases
Hamburg, Germany – 2 September 2010: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced the Closing of the agreement to acquire DeveloGen as announced in detail on 14 July 2010. Following the successful fulfilment of various Closing conditions, the sellers of 99.3% of the shares in... (...)
Geneva, Switzerland, 2 September 2010 – Allosteric modulation company Addex Pharmaceuticals Ltd (SIX: ADXN) announced today that it has observed efficacy in a model of Alzheimer’s disease using a recently discovered orally-available drug-candidate. The proprietary molecule specifically inhibits a... (...)
Oxford, UK and Langhorne, PA, USA – 1 September 2010 EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced the appointment of Stephen A. Stamp to the company’s Board as an independent Non-Executive Director. Mr Stamp... (...)
Geneva, Switzerland, 25 August 2010 - Allosteric modulation company Addex Pharmaceuticals Ltd (SIX:ADXN) announced today that the Phase I studies required to commence Phase II testing of ADX71149 have been satisfactorily completed. Subject to regulatory authorizations, Phase IIa studies in... (...)
Cambridge, MA - August 20, 2010 - Anchor Therapeutics today announced an initial closing of $10 million in a Series B financing. The investment is being led by current investors TVM Capital, HealthCare Ventures and the Novartis Option Fund. The company is in continuing discussions with additional... (...)
DRUG DISCOVERY BUSINESS REPORTS STRONG REVENUE GROWTH (+33%) AND A POSITIVE OPERATING RESULT OF € 0.3 M; REVENUE GUIDANCE RAISED FOR THE FULL YEAR 2010 Hamburg, Germany - 12 August 2010: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today reported financial results and corporate updates for... (...)
August 10, 2010 Lexington, MA –– Concert Pharmaceuticals, Inc. today announced that Gregory L. Miller has joined the company as its new Head of Business and Corporate Development. In this role, Greg will focus on leading Concert’s business development efforts and play a key part in strategic... (...)
Planegg/Munich (Germany), Princeton, NJ and Houston, TX, August 5, 2010 – Agennix AG (Frankfurt Stock Exchange: AGX) today provided an update on its development status and plans for oral talactoferrin. Enrollment on track in Phase III FORTIS-M trial in non-small cell lung cancer The Company... (...)
Hamburg, Germany - 4 August 2010: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a payment of EUR 2.5 million to Evotec. The milestone reached was the selection of a candidate compound for... (...)
NORTHBROOK, IL – August 3, 2010 – Horizon Pharma, Inc. announced today that it has filed a registration statement on form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be... (...)
Next results →